APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Cloning Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Cloning Service Market Outlook and Growth Opportunities 2026

4 June 2026212 pages

Choose your research edition.

Industry ResearchDNA Cloning Service Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Cloning Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal DNA Cloning Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Cloning Service Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Cloning Service Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global DNA Cloning Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Cloning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Cloning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Cloning Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Cloning Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Cloning Service market include Genscript Biotech, Yunzhou Biosciences, Twist Bioscience Corporation, Azenta, Eurofins Genomics, Thermo Fisher Scientific, Synbio Technologies, Bioneer Corporation and Macrogen, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA Cloning Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Cloning Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Cloning Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Cloning Service market.

DNA Cloning Service Segment by Company

Genscript Biotech

Yunzhou Biosciences

Twist Bioscience Corporation

Azenta

Eurofins Genomics

Thermo Fisher Scientific

Synbio Technologies

Bioneer Corporation

Macrogen, Inc.

OriGene Technologies

Creative Biogene

InvivoGen

Bio Basic Inc.

Biomatik

GeneCopoeia, Inc.

NovoPro Bioscience Inc.

System Biosciences

Porton Advanced

uBriGene

Aurigene Services

Beijing Tsingke Biotech

Sangon Biotech

Shandong Vigene Biosciences

Shanghai Medicilon

Shanghai Integrated Biotech Solutions

Wuhan Miaoling Biotechnology

Shanghai ShineGene Molecular Biotechnology

FASMAC

DNA Cloning Service e.K.

PlasmidFactory GmbH

DNA Cloning Service Segment by Type

Common Plasmid

Expression Plasmid

Phage Vector

Other

DNA Cloning Service Segment by Application

Biomedicine

Gene and Cell Therapy

Research Institutions

Synthetic Biology

Other

DNA Cloning Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Cloning Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Cloning Service key companies, revenue, market share, and recent developments.

3. To split the DNA Cloning Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Cloning Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Cloning Service significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Cloning Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Cloning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Cloning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Cloning Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Cloning Service industry.

Chapter 3: Detailed analysis of DNA Cloning Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Cloning Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Cloning Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Cloning Service Industry Trends Table 2. DNA Cloning Service Industry Drivers Table 3. DNA Cloning Service Industry Opportunities and Challenges Table 4. DNA Cloning Service Industry Restraints Table 5. Global DNA Cloning Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Cloning Service Revenue Share by Company (2021-2026) Table 7. Global DNA Cloning Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Cloning Service Key Company Manufacturing Base & Headquarters Table 9. Global DNA Cloning Service Company, Product Type & Application Table 10. Global DNA Cloning Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Cloning Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Common Plasmid Table 15. Significant Companies of Expression Plasmid Table 16. Significant Companies of Phage Vector Table 17. Significant Companies of Other Table 18. Global DNA Cloning Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global DNA Cloning Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global DNA Cloning Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global DNA Cloning Service Sales Value Share by Type (2021-2026) Table 22. Global DNA Cloning Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biomedicine Table 24. Significant Companies of Gene and Cell Therapy Table 25. Significant Companies of Research Institutions Table 26. Significant Companies of Synthetic Biology Table 27. Significant Companies of Other Table 28. Global DNA Cloning Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global DNA Cloning Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global DNA Cloning Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global DNA Cloning Service Sales Value Share by Application (2021-2026) Table 32. Global DNA Cloning Service Sales Value Share by Application (2027-2032) Table 33. Global DNA Cloning Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global DNA Cloning Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global DNA Cloning Service Sales Value Share by Region (2021-2026) Table 36. Global DNA Cloning Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global DNA Cloning Service Sales Value Share by Region (2027-2032) Table 38. Global DNA Cloning Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global DNA Cloning Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global DNA Cloning Service Sales Value Market Share by Country (2021-2026) Table 41. Global DNA Cloning Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global DNA Cloning Service Sales Value Market Share by Country (2027-2032) Table 43. Genscript Biotech Company Information Table 44. Genscript Biotech Business Overview Table 45. Genscript Biotech DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Genscript Biotech DNA Cloning Service Product Portfolio Table 47. Genscript Biotech Recent Development Table 48. Yunzhou Biosciences Company Information Table 49. Yunzhou Biosciences Business Overview Table 50. Yunzhou Biosciences DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Yunzhou Biosciences DNA Cloning Service Product Portfolio Table 52. Yunzhou Biosciences Recent Development Table 53. Twist Bioscience Corporation Company Information Table 54. Twist Bioscience Corporation Business Overview Table 55. Twist Bioscience Corporation DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Twist Bioscience Corporation DNA Cloning Service Product Portfolio Table 57. Twist Bioscience Corporation Recent Development Table 58. Azenta Company Information Table 59. Azenta Business Overview Table 60. Azenta DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Azenta DNA Cloning Service Product Portfolio Table 62. Azenta Recent Development Table 63. Eurofins Genomics Company Information Table 64. Eurofins Genomics Business Overview Table 65. Eurofins Genomics DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Eurofins Genomics DNA Cloning Service Product Portfolio Table 67. Eurofins Genomics Recent Development Table 68. Thermo Fisher Scientific Company Information Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific DNA Cloning Service Product Portfolio Table 72. Thermo Fisher Scientific Recent Development Table 73. Synbio Technologies Company Information Table 74. Synbio Technologies Business Overview Table 75. Synbio Technologies DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Synbio Technologies DNA Cloning Service Product Portfolio Table 77. Synbio Technologies Recent Development Table 78. Bioneer Corporation Company Information Table 79. Bioneer Corporation Business Overview Table 80. Bioneer Corporation DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bioneer Corporation DNA Cloning Service Product Portfolio Table 82. Bioneer Corporation Recent Development Table 83. Macrogen, Inc. Company Information Table 84. Macrogen, Inc. Business Overview Table 85. Macrogen, Inc. DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Macrogen, Inc. DNA Cloning Service Product Portfolio Table 87. Macrogen, Inc. Recent Development Table 88. OriGene Technologies Company Information Table 89. OriGene Technologies Business Overview Table 90. OriGene Technologies DNA Cloning Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. OriGene Technologies DNA Cloning Service Product Portfolio Table 92. OriGene Technologies Recent Development Table 93. Creative Biogene Company Information Table 94. Creative Biogene Business Overview Table 95. Creative Biogene DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Creative Biogene DNA Cloning Service Product Portfolio Table 97. Creative Biogene Recent Development Table 98. InvivoGen Company Information Table 99. InvivoGen Business Overview Table 100. InvivoGen DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. InvivoGen DNA Cloning Service Product Portfolio Table 102. InvivoGen Recent Development Table 103. Bio Basic Inc. Company Information Table 104. Bio Basic Inc. Business Overview Table 105. Bio Basic Inc. DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Bio Basic Inc. DNA Cloning Service Product Portfolio Table 107. Bio Basic Inc. Recent Development Table 108. Biomatik Company Information Table 109. Biomatik Business Overview Table 110. Biomatik DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Biomatik DNA Cloning Service Product Portfolio Table 112. Biomatik Recent Development Table 113. GeneCopoeia, Inc. Company Information Table 114. GeneCopoeia, Inc. Business Overview Table 115. GeneCopoeia, Inc. DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. GeneCopoeia, Inc. DNA Cloning Service Product Portfolio Table 117. GeneCopoeia, Inc. Recent Development Table 118. NovoPro Bioscience Inc. Company Information Table 119. NovoPro Bioscience Inc. Business Overview Table 120. NovoPro Bioscience Inc. DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. NovoPro Bioscience Inc. DNA Cloning Service Product Portfolio Table 122. NovoPro Bioscience Inc. Recent Development Table 123. System Biosciences Company Information Table 124. System Biosciences Business Overview Table 125. System Biosciences DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. System Biosciences DNA Cloning Service Product Portfolio Table 127. System Biosciences Recent Development Table 128. Porton Advanced Company Information Table 129. Porton Advanced Business Overview Table 130. Porton Advanced DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Porton Advanced DNA Cloning Service Product Portfolio Table 132. Porton Advanced Recent Development Table 133. uBriGene Company Information Table 134. uBriGene Business Overview Table 135. uBriGene DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. uBriGene DNA Cloning Service Product Portfolio Table 137. uBriGene Recent Development Table 138. Aurigene Services Company Information Table 139. Aurigene Services Business Overview Table 140. Aurigene Services DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Aurigene Services DNA Cloning Service Product Portfolio Table 142. Aurigene Services Recent Development Table 143. Beijing Tsingke Biotech Company Information Table 144. Beijing Tsingke Biotech Business Overview Table 145. Beijing Tsingke Biotech DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Beijing Tsingke Biotech DNA Cloning Service Product Portfolio Table 147. Beijing Tsingke Biotech Recent Development Table 148. Sangon Biotech Company Information Table 149. Sangon Biotech Business Overview Table 150. Sangon Biotech DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Sangon Biotech DNA Cloning Service Product Portfolio Table 152. Sangon Biotech Recent Development Table 153. Shandong Vigene Biosciences Company Information Table 154. Shandong Vigene Biosciences Business Overview Table 155. Shandong Vigene Biosciences DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Shandong Vigene Biosciences DNA Cloning Service Product Portfolio Table 157. Shandong Vigene Biosciences Recent Development Table 158. Shanghai Medicilon Company Information Table 159. Shanghai Medicilon Business Overview Table 160. Shanghai Medicilon DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Shanghai Medicilon DNA Cloning Service Product Portfolio Table 162. Shanghai Medicilon Recent Development Table 163. Shanghai Integrated Biotech Solutions Company Information Table 164. Shanghai Integrated Biotech Solutions Business Overview Table 165. Shanghai Integrated Biotech Solutions DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Shanghai Integrated Biotech Solutions DNA Cloning Service Product Portfolio Table 167. Shanghai Integrated Biotech Solutions Recent Development Table 168. Wuhan Miaoling Biotechnology Company Information Table 169. Wuhan Miaoling Biotechnology Business Overview Table 170. Wuhan Miaoling Biotechnology DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Wuhan Miaoling Biotechnology DNA Cloning Service Product Portfolio Table 172. Wuhan Miaoling Biotechnology Recent Development Table 173. Shanghai ShineGene Molecular Biotechnology Company Information Table 174. Shanghai ShineGene Molecular Biotechnology Business Overview Table 175. Shanghai ShineGene Molecular Biotechnology DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. Shanghai ShineGene Molecular Biotechnology DNA Cloning Service Product Portfolio Table 177. Shanghai ShineGene Molecular Biotechnology Recent Development Table 178. FASMAC Company Information Table 179. FASMAC Business Overview Table 180. FASMAC DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. FASMAC DNA Cloning Service Product Portfolio Table 182. FASMAC Recent Development Table 183. DNA Cloning Service e.K. Company Information Table 184. DNA Cloning Service e.K. Business Overview Table 185. DNA Cloning Service e.K. DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. DNA Cloning Service e.K. DNA Cloning Service Product Portfolio Table 187. DNA Cloning Service e.K. Recent Development Table 188. PlasmidFactory GmbH Company Information Table 189. PlasmidFactory GmbH Business Overview Table 190. PlasmidFactory GmbH DNA Cloning Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 191. PlasmidFactory GmbH DNA Cloning Service Product Portfolio Table 192. PlasmidFactory GmbH Recent Development Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. DNA Cloning Service Product Image Figure 2. Global DNA Cloning Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Cloning Service Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Cloning Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Common Plasmid Image Figure 8. Expression Plasmid Image Figure 9. Phage Vector Image Figure 10. Other Image Figure 11. Global DNA Cloning Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global DNA Cloning Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global DNA Cloning Service Sales Value Share by Type (2021-2032) Figure 14. Biomedicine Image Figure 15. Gene and Cell Therapy Image Figure 16. Research Institutions Image Figure 17. Synthetic Biology Image Figure 18. Other Image Figure 19. Global DNA Cloning Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global DNA Cloning Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global DNA Cloning Service Sales Value Share by Application (2021-2032) Figure 22. Global DNA Cloning Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global DNA Cloning Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America DNA Cloning Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America DNA Cloning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe DNA Cloning Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe DNA Cloning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific DNA Cloning Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific DNA Cloning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America DNA Cloning Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America DNA Cloning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa DNA Cloning Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa DNA Cloning Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt DNA Cloning Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt DNA Cloning Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt DNA Cloning Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Common Plasmid
  • Expression Plasmid
  • Phage Vector
  • Other
Applications
  • Biomedicine
  • Gene and Cell Therapy
  • Research Institutions
  • Synthetic Biology
  • Other
Companies covered
  • Genscript Biotech
  • Yunzhou Biosciences
  • Twist Bioscience Corporation
  • Azenta
  • Eurofins Genomics
  • Thermo Fisher Scientific
  • Synbio Technologies
  • Bioneer Corporation
  • Macrogen, Inc.
  • OriGene Technologies
  • Creative Biogene
  • InvivoGen
  • Bio Basic Inc.
  • Biomatik
  • GeneCopoeia, Inc.
  • NovoPro Bioscience Inc.
  • System Biosciences
  • Porton Advanced
  • uBriGene
  • Aurigene Services
  • Beijing Tsingke Biotech
  • Sangon Biotech
  • Shandong Vigene Biosciences
  • Shanghai Medicilon
  • Shanghai Integrated Biotech Solutions
  • Wuhan Miaoling Biotechnology
  • Shanghai ShineGene Molecular Biotechnology
  • FASMAC
  • DNA Cloning Service e.K.
  • PlasmidFactory GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Cloning Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Cloning Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Cloning Service Market Dynamics
  1. 2.1 DNA Cloning Service Industry Trends
  2. 2.2 DNA Cloning Service Industry Drivers
  3. 2.3 DNA Cloning Service Industry Opportunities and Challenges
  4. 2.4 DNA Cloning Service Industry Restraints
3 DNA Cloning Service Market by Company
  1. 3.1 Global DNA Cloning Service Company Revenue Ranking in 2025
  2. 3.2 Global DNA Cloning Service Revenue by Company (2021-2026)
  3. 3.3 Global DNA Cloning Service Company Ranking (2024-2026)
  4. 3.4 Global DNA Cloning Service Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Cloning Service Company Product Type and Application
  6. 3.6 Global DNA Cloning Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Cloning Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Cloning Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Cloning Service Market by Type
  1. 4.1 DNA Cloning Service Type Introduction
  2. 4.1.1 Common Plasmid
  3. 4.1.2 Expression Plasmid
  4. 4.1.3 Phage Vector
  5. 4.1.4 Other
  6. 4.2 Global DNA Cloning Service Sales Value by Type
  7. 4.2.1 Global DNA Cloning Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global DNA Cloning Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global DNA Cloning Service Sales Value Share by Type (2021-2032)
5 DNA Cloning Service Market by Application
  1. 5.1 DNA Cloning Service Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Gene and Cell Therapy
  4. 5.1.3 Research Institutions
  5. 5.1.4 Synthetic Biology
  6. 5.1.5 Other
  7. 5.2 Global DNA Cloning Service Sales Value by Application
  8. 5.2.1 Global DNA Cloning Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global DNA Cloning Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global DNA Cloning Service Sales Value Share by Application (2021-2032)
6 DNA Cloning Service Regional Value Analysis
  1. 6.1 Global DNA Cloning Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Cloning Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Cloning Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Cloning Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Cloning Service Sales Value (2021-2032)
  7. 6.3.2 North America DNA Cloning Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Cloning Service Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Cloning Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Cloning Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Cloning Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Cloning Service Sales Value (2021-2032)
  16. 6.6.2 South America DNA Cloning Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Cloning Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Cloning Service Sales Value Share by Country, 2025 VS 2032
7 DNA Cloning Service Country-level Value Analysis
  1. 7.1 Global DNA Cloning Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Cloning Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Cloning Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Cloning Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Cloning Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Cloning Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Cloning Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Cloning Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Cloning Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Cloning Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Cloning Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Cloning Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Cloning Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Cloning Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Cloning Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Cloning Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Cloning Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Cloning Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Cloning Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Cloning Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Cloning Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Cloning Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Cloning Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Cloning Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Cloning Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Cloning Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Cloning Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Cloning Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Cloning Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Cloning Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Cloning Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Cloning Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Cloning Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Cloning Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genscript Biotech
  2. 8.1.1 Genscript Biotech Company Information
  3. 8.1.2 Genscript Biotech Business Overview
  4. 8.1.3 Genscript Biotech DNA Cloning Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genscript Biotech DNA Cloning Service Product Portfolio
  6. 8.1.5 Genscript Biotech Recent Developments
  7. 8.2 Yunzhou Biosciences
  8. 8.2.1 Yunzhou Biosciences Company Information
  9. 8.2.2 Yunzhou Biosciences Business Overview
  10. 8.2.3 Yunzhou Biosciences DNA Cloning Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yunzhou Biosciences DNA Cloning Service Product Portfolio
  12. 8.2.5 Yunzhou Biosciences Recent Developments
  13. 8.3 Twist Bioscience Corporation
  14. 8.3.1 Twist Bioscience Corporation Company Information
  15. 8.3.2 Twist Bioscience Corporation Business Overview
  16. 8.3.3 Twist Bioscience Corporation DNA Cloning Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Twist Bioscience Corporation DNA Cloning Service Product Portfolio
  18. 8.3.5 Twist Bioscience Corporation Recent Developments
  19. 8.4 Azenta
  20. 8.4.1 Azenta Company Information
  21. 8.4.2 Azenta Business Overview
  22. 8.4.3 Azenta DNA Cloning Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Azenta DNA Cloning Service Product Portfolio
  24. 8.4.5 Azenta Recent Developments
  25. 8.5 Eurofins Genomics
  26. 8.5.1 Eurofins Genomics Company Information
  27. 8.5.2 Eurofins Genomics Business Overview
  28. 8.5.3 Eurofins Genomics DNA Cloning Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Genomics DNA Cloning Service Product Portfolio
  30. 8.5.5 Eurofins Genomics Recent Developments
  31. 8.6 Thermo Fisher Scientific
  32. 8.6.1 Thermo Fisher Scientific Company Information
  33. 8.6.2 Thermo Fisher Scientific Business Overview
  34. 8.6.3 Thermo Fisher Scientific DNA Cloning Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Scientific DNA Cloning Service Product Portfolio
  36. 8.6.5 Thermo Fisher Scientific Recent Developments
  37. 8.7 Synbio Technologies
  38. 8.7.1 Synbio Technologies Company Information
  39. 8.7.2 Synbio Technologies Business Overview
  40. 8.7.3 Synbio Technologies DNA Cloning Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Synbio Technologies DNA Cloning Service Product Portfolio
  42. 8.7.5 Synbio Technologies Recent Developments
  43. 8.8 Bioneer Corporation
  44. 8.8.1 Bioneer Corporation Company Information
  45. 8.8.2 Bioneer Corporation Business Overview
  46. 8.8.3 Bioneer Corporation DNA Cloning Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bioneer Corporation DNA Cloning Service Product Portfolio
  48. 8.8.5 Bioneer Corporation Recent Developments
  49. 8.9 Macrogen, Inc.
  50. 8.9.1 Macrogen, Inc. Company Information
  51. 8.9.2 Macrogen, Inc. Business Overview
  52. 8.9.3 Macrogen, Inc. DNA Cloning Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Macrogen, Inc. DNA Cloning Service Product Portfolio
  54. 8.9.5 Macrogen, Inc. Recent Developments
  55. 8.10 OriGene Technologies
  56. 8.10.1 OriGene Technologies Company Information
  57. 8.10.2 OriGene Technologies Business Overview
  58. 8.10.3 OriGene Technologies DNA Cloning Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 OriGene Technologies DNA Cloning Service Product Portfolio
  60. 8.10.5 OriGene Technologies Recent Developments
  61. 8.11 Creative Biogene
  62. 8.11.1 Creative Biogene Company Information
  63. 8.11.2 Creative Biogene Business Overview
  64. 8.11.3 Creative Biogene DNA Cloning Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Biogene DNA Cloning Service Product Portfolio
  66. 8.11.5 Creative Biogene Recent Developments
  67. 8.12 InvivoGen
  68. 8.12.1 InvivoGen Company Information
  69. 8.12.2 InvivoGen Business Overview
  70. 8.12.3 InvivoGen DNA Cloning Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InvivoGen DNA Cloning Service Product Portfolio
  72. 8.12.5 InvivoGen Recent Developments
  73. 8.13 Bio Basic Inc.
  74. 8.13.1 Bio Basic Inc. Company Information
  75. 8.13.2 Bio Basic Inc. Business Overview
  76. 8.13.3 Bio Basic Inc. DNA Cloning Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bio Basic Inc. DNA Cloning Service Product Portfolio
  78. 8.13.5 Bio Basic Inc. Recent Developments
  79. 8.14 Biomatik
  80. 8.14.1 Biomatik Company Information
  81. 8.14.2 Biomatik Business Overview
  82. 8.14.3 Biomatik DNA Cloning Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biomatik DNA Cloning Service Product Portfolio
  84. 8.14.5 Biomatik Recent Developments
  85. 8.15 GeneCopoeia, Inc.
  86. 8.15.1 GeneCopoeia, Inc. Company Information
  87. 8.15.2 GeneCopoeia, Inc. Business Overview
  88. 8.15.3 GeneCopoeia, Inc. DNA Cloning Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GeneCopoeia, Inc. DNA Cloning Service Product Portfolio
  90. 8.15.5 GeneCopoeia, Inc. Recent Developments
  91. 8.16 NovoPro Bioscience Inc.
  92. 8.16.1 NovoPro Bioscience Inc. Company Information
  93. 8.16.2 NovoPro Bioscience Inc. Business Overview
  94. 8.16.3 NovoPro Bioscience Inc. DNA Cloning Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NovoPro Bioscience Inc. DNA Cloning Service Product Portfolio
  96. 8.16.5 NovoPro Bioscience Inc. Recent Developments
  97. 8.17 System Biosciences
  98. 8.17.1 System Biosciences Company Information
  99. 8.17.2 System Biosciences Business Overview
  100. 8.17.3 System Biosciences DNA Cloning Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 System Biosciences DNA Cloning Service Product Portfolio
  102. 8.17.5 System Biosciences Recent Developments
  103. 8.18 Porton Advanced
  104. 8.18.1 Porton Advanced Company Information
  105. 8.18.2 Porton Advanced Business Overview
  106. 8.18.3 Porton Advanced DNA Cloning Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Porton Advanced DNA Cloning Service Product Portfolio
  108. 8.18.5 Porton Advanced Recent Developments
  109. 8.19 uBriGene
  110. 8.19.1 uBriGene Company Information
  111. 8.19.2 uBriGene Business Overview
  112. 8.19.3 uBriGene DNA Cloning Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 uBriGene DNA Cloning Service Product Portfolio
  114. 8.19.5 uBriGene Recent Developments
  115. 8.20 Aurigene Services
  116. 8.20.1 Aurigene Services Company Information
  117. 8.20.2 Aurigene Services Business Overview
  118. 8.20.3 Aurigene Services DNA Cloning Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aurigene Services DNA Cloning Service Product Portfolio
  120. 8.20.5 Aurigene Services Recent Developments
  121. 8.21 Beijing Tsingke Biotech
  122. 8.21.1 Beijing Tsingke Biotech Company Information
  123. 8.21.2 Beijing Tsingke Biotech Business Overview
  124. 8.21.3 Beijing Tsingke Biotech DNA Cloning Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Beijing Tsingke Biotech DNA Cloning Service Product Portfolio
  126. 8.21.5 Beijing Tsingke Biotech Recent Developments
  127. 8.22 Sangon Biotech
  128. 8.22.1 Sangon Biotech Company Information
  129. 8.22.2 Sangon Biotech Business Overview
  130. 8.22.3 Sangon Biotech DNA Cloning Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sangon Biotech DNA Cloning Service Product Portfolio
  132. 8.22.5 Sangon Biotech Recent Developments
  133. 8.23 Shandong Vigene Biosciences
  134. 8.23.1 Shandong Vigene Biosciences Company Information
  135. 8.23.2 Shandong Vigene Biosciences Business Overview
  136. 8.23.3 Shandong Vigene Biosciences DNA Cloning Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Shandong Vigene Biosciences DNA Cloning Service Product Portfolio
  138. 8.23.5 Shandong Vigene Biosciences Recent Developments
  139. 8.24 Shanghai Medicilon
  140. 8.24.1 Shanghai Medicilon Company Information
  141. 8.24.2 Shanghai Medicilon Business Overview
  142. 8.24.3 Shanghai Medicilon DNA Cloning Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Shanghai Medicilon DNA Cloning Service Product Portfolio
  144. 8.24.5 Shanghai Medicilon Recent Developments
  145. 8.25 Shanghai Integrated Biotech Solutions
  146. 8.25.1 Shanghai Integrated Biotech Solutions Company Information
  147. 8.25.2 Shanghai Integrated Biotech Solutions Business Overview
  148. 8.25.3 Shanghai Integrated Biotech Solutions DNA Cloning Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Shanghai Integrated Biotech Solutions DNA Cloning Service Product Portfolio
  150. 8.25.5 Shanghai Integrated Biotech Solutions Recent Developments
  151. 8.26 Wuhan Miaoling Biotechnology
  152. 8.26.1 Wuhan Miaoling Biotechnology Company Information
  153. 8.26.2 Wuhan Miaoling Biotechnology Business Overview
  154. 8.26.3 Wuhan Miaoling Biotechnology DNA Cloning Service Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Wuhan Miaoling Biotechnology DNA Cloning Service Product Portfolio
  156. 8.26.5 Wuhan Miaoling Biotechnology Recent Developments
  157. 8.27 Shanghai ShineGene Molecular Biotechnology
  158. 8.27.1 Shanghai ShineGene Molecular Biotechnology Company Information
  159. 8.27.2 Shanghai ShineGene Molecular Biotechnology Business Overview
  160. 8.27.3 Shanghai ShineGene Molecular Biotechnology DNA Cloning Service Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Shanghai ShineGene Molecular Biotechnology DNA Cloning Service Product Portfolio
  162. 8.27.5 Shanghai ShineGene Molecular Biotechnology Recent Developments
  163. 8.28 FASMAC
  164. 8.28.1 FASMAC Company Information
  165. 8.28.2 FASMAC Business Overview
  166. 8.28.3 FASMAC DNA Cloning Service Revenue and Gross Margin (2021-2026)
  167. 8.28.4 FASMAC DNA Cloning Service Product Portfolio
  168. 8.28.5 FASMAC Recent Developments
  169. 8.29 DNA Cloning Service e.K.
  170. 8.29.1 DNA Cloning Service e.K. Company Information
  171. 8.29.2 DNA Cloning Service e.K. Business Overview
  172. 8.29.3 DNA Cloning Service e.K. DNA Cloning Service Revenue and Gross Margin (2021-2026)
  173. 8.29.4 DNA Cloning Service e.K. DNA Cloning Service Product Portfolio
  174. 8.29.5 DNA Cloning Service e.K. Recent Developments
  175. 8.30 PlasmidFactory GmbH
  176. 8.30.1 PlasmidFactory GmbH Company Information
  177. 8.30.2 PlasmidFactory GmbH Business Overview
  178. 8.30.3 PlasmidFactory GmbH DNA Cloning Service Revenue and Gross Margin (2021-2026)
  179. 8.30.4 PlasmidFactory GmbH DNA Cloning Service Product Portfolio
  180. 8.30.5 PlasmidFactory GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst